Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors JF Shern, L Chen, J Chmielecki, JS Wei, R Patidar, M Rosenberg, ... Cancer discovery 4 (2), 216-231, 2014 | 737 | 2014 |
Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma D Bogen, JS Wei, DO Azorsa, P Ormanoglu, E Buehler, R Guha, JM Keller, ... Oncotarget 6 (34), 35247, 2015 | 58 | 2015 |
Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study AP Berbegall, D Bogen, U Pötschger, K Beiske, N Bown, V Combaret, ... British journal of cancer 118 (11), 1502-1512, 2018 | 53 | 2018 |
The genetic tumor background is an important determinant for heterogeneous MYCN‐amplified neuroblastoma D Bogen, C Brunner, D Walder, A Ziegler, R Abbasi, RL Ladenstein, ... International journal of cancer 139 (1), 153-163, 2016 | 40 | 2016 |
Hepatitis C Virus-Induced Secretion of Inflammatory Chemokines Preferentially Recruits NKG2A+CD8+ T Cells J Nattermann, R Sherzada, A Iwan, D Bogen, IM Niederle, D Schulte, ... The Journal of infectious diseases 198 (2), 213-217, 2008 | 10 | 2008 |
Machine learning framework incorporating expert knowledge in tissue image annotation F Kromp, I Ambros, T Weiss, D Bogen, H Dodig, M Berneder, T Gerber, ... 2016 23rd International Conference on Pattern Recognition (ICPR), 343-348, 2016 | 7 | 2016 |
Visualization of intra tumor heterogeneity by simultaneous analysis of tumor and liquid biopsy samples in stage M neuroblastomas T Gerber, LJ Barber, SC Huetter, D Bogen, MN Davies, I Assiotis, ... Klinische Pädiatrie 229 (03), A30, 2017 | | 2017 |
Abstract B31: Combined siRNA and small molecule screening identifies Aurora B kinase as an effective target in MYCN-driven neuroblastoma D Bogen, JS Wei, DO Azorsa, P Ormanoglu, E Buehler, R Guha, JM Keller, ... Cancer Research 76 (5_Supplement), B31-B31, 2016 | | 2016 |
Abstract B56: Genomic background of neuroblastomas with intratumor heterogeneity of MYCN amplification IM Ambros, C Brunner, D Bogen, G Amann, R Abbasi, B Gürtl-Lackner, ... Cancer Research 74 (20_Supplement), B56-B56, 2014 | | 2014 |
Genomic background of neuroblastomas with intratumour heterogeneity of MYCN amplification PF Ambros, D Bogen, C Brunner, G Amann, B Guertl-Lackner, R Abbasi, ... EUROPEAN JOURNAL OF CANCER 49, S351-S351, 2013 | | 2013 |
Synthetic lethal siRNA screening to identify novel combinational therapies with Topotecan in neuroblastoma. D Bogen, EC Buehler, P Tuzmen, R Patidar, D Azorsa, YK Song, H Liao, ... Cancer Research 73 (8_Supplement), 4398-4398, 2013 | | 2013 |
Massively parallel transcriptome sequencing in neuroblastoma reveals specific mRNA splicing patterns controlled by RNA binding splicing factors. S Zhang, T Badgett, J Wei, YK Song, D Bogen, P Johansson, C Tolman, ... Cancer Research 73 (8_Supplement), 3161-3161, 2013 | | 2013 |
Amplicon, genomic background and genome instability in heterogeneous MYCN amplified neuroblastoma D Bogen, IM Ambros, G Amann, E Spuller, J Erichsen, B Brunner, ... Klinische Pädiatrie 222 (03), A17, 2010 | | 2010 |
Die Hepatitis C Virus-induzierte Freisetzung inflammatorischer Chemokine führt zu einer präferenziellen Rekrutierung NKG2A-exprimierender CD8+ T Zellen J Nattermann, R Sherzada, A Iwan, D Bogen, IM Niederle, D Schulte, ... Zeitschrift für Gastroenterologie 46 (09), P092, 2008 | | 2008 |
120 HEPATITIS C VIRUS-INDUCED SECRETION OF INFLAMMATORY CHEMOKINES PREFERENTIALLY RECRUIT NKG2A EXPRESSING CD8 T CELLS J Nattermann, R Sherzada, A Iwan, D Bogen, IM Niederle, D Schulte, ... Journal of Hepatology 48 (2), 5, 2008 | | 2008 |
[456] NKG2A-POSITIVE CD8+ T CELLS IN CHRONIC HEPATITIS C J Nattermann, R Sherzada, D Bogen, A Iwan, HD Nischalke, B Kramer, ... Journal of Hepatology, S173-S174, 2007 | | 2007 |
Charakterisierung NKG2A-positiver CD8+ T bei der HCV-Infektion J Nattermann, R Sherzada, D Bogen, A Iwan, HD Nischalke, B Krämer, ... Zeitschrift für Gastroenterologie 45 (01), A4_18, 2007 | | 2007 |
CHARACTERIZATION OF NKG2A-POSITIVE CD8+ T CELLS IN HCV INFECTION: 414 J Nattermann, R Sherzada, D Bogen, A Iwan, HD Nischalke, B Krämer, ... Hepatology 44, 345A, 2006 | | 2006 |